MICROPORT CARDIO.MEDTECH. - Asset Resilience Ratio
MICROPORT CARDIO.MEDTECH. (72X) has an Asset Resilience Ratio of 37.03% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See MICROPORT CARDIO.MEDTECH. financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2024)
This chart shows how MICROPORT CARDIO.MEDTECH.'s Asset Resilience Ratio has changed over time. See MICROPORT CARDIO.MEDTECH. balance sheet quality to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down MICROPORT CARDIO.MEDTECH.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 72X company net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €987.89 Million | 37.03% |
| Total Liquid Assets | €987.89 Million | 37.03% |
Asset Resilience Insights
- Very High Liquidity: MICROPORT CARDIO.MEDTECH. maintains exceptional liquid asset reserves at 37.03% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
MICROPORT CARDIO.MEDTECH. Industry Peers by Asset Resilience Ratio
Compare MICROPORT CARDIO.MEDTECH.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medacta Group SA
SW:MOVE |
Medical Devices | 0.86% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Xiangyu Medical Co. Ltd. A
SHG:688626 |
Medical Devices | 1.53% |
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 5.73% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
Annual Asset Resilience Ratio for MICROPORT CARDIO.MEDTECH. (2022–2024)
The table below shows the annual Asset Resilience Ratio data for MICROPORT CARDIO.MEDTECH..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 46.74% | €1.25 Billion ≈ $1.46 Billion |
€2.68 Billion ≈ $3.13 Billion |
+19.26pp |
| 2023-12-31 | 27.48% | €708.27 Million ≈ $828.04 Million |
€2.58 Billion ≈ $3.01 Billion |
+20.52pp |
| 2022-12-31 | 6.96% | €208.94 Million ≈ $244.27 Million |
€3.00 Billion ≈ $3.51 Billion |
-- |
About MICROPORT CARDIO.MEDTECH.
MicroPort CardioFlow Medtech Corporation, a medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People's Republic of China and internationally. The company engages in research and development, manufacture, and sale of medical devices in the field of left atrial appendage, and treating valv… Read more